These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5964547)

  • 21. Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.
    Pyle MM
    Ann N Y Acad Sci; 1966 Apr; 135(2):835-45. PubMed ID: 5220243
    [No Abstract]   [Full Text] [Related]  

  • 22. [Non-tuberculous Mycobacteria: epidemiologic importance and current pathogenicity].
    De Haller R; Piguet JD; De Haller J
    Schweiz Med Wochenschr; 1983 Jan; 113(3):80-7. PubMed ID: 6338585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacement of streptomycin by ethambutol in the intensive phase of tuberculosis treatment: no effect on compliance.
    Rabarijaona L; Boisier P; Ratsirahonana O; Razafinimanana J; Rakotomanana F; Ratsitorahina M; Ramarokoto H; Cauchoix B; Aurégan G
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):42-6. PubMed ID: 10094168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimycobacterial drugs.
    Heifets LB
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of atypical mycobacterioses].
    Daddi G
    Rev Tuberc Pneumol (Paris); 1970; 34(1):53-7. PubMed ID: 5517743
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental atypical mycobacterial infection].
    Kuze F
    Kekkaku; 1983 Sep; 58(9):469-88. PubMed ID: 6363795
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of disease caused by nontuberculous mycobacteria.
    Bass JB; Hawkins EL
    Arch Intern Med; 1983 Jul; 143(7):1439-41. PubMed ID: 6870414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
    Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS
    Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
    Kabedi MJ; Kashongwe M; Kayembe JM; Mumba Ngoyi D; Mampasi P; Mbaya P; Fissette K; Verhaegen J; Portaels F; Muyembe-Tamfum JJ
    Bull Soc Pathol Exot; 2007 Oct; 100(4):275-6. PubMed ID: 17982858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulmonary tuberculosis or MOTT infection in kidney transplant recipients.
    Chen CH; Hsieh H; Lai MK
    Transplant Proc; 1994 Aug; 26(4):2136-7. PubMed ID: 8066697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Atypical mycobacterium infections].
    Decraemere W
    Cah Med; 1973 Oct; 14(10):843-6. PubMed ID: 4806158
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 40. [Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
    Gruschke A; Enzensberger R; Brade V
    Dtsch Med Wochenschr; 2002 Sep; 127(38):1947-50. PubMed ID: 12239654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.